Drawing for RHEOGENE

USPTO serial 86399255

RHEOGENE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MARTIN, LIEF ANDREW
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RHEOGENE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David L. May

DAVID L. MAY NIXON PEABODY LLP401 9TH ST NW STE 900WASHINGTON, DC 20004-2145UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals, biochemicals and reagents for use in industry and science; Chemicals, biochemicals and reagents for use in industry and science, namely, for use in the biochemical and chemical industry, agriculture, food production, energy conversion, biotechnological product development, biotechnological manufacturing processes, and production of environmentally-friendly chemical solutions; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression in plants, mammals, fungi and microbes for industrial, agricultural scientific, research, pharmaceutical discovery, pharmaceutical development purposes, and non-medical purposes; kits consisting primarily of proteins for regulating, modifying or restricting gene expressionACTIVE—
005Chemical preparations for medical and veterinary purposes, namely, chemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for gene therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for gene therapy analysis; chemical reagents for medical and veterinary purposesACTIVE—
042Development of products being genetic therapies and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the field of biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory useACTIVE—
044Medical services; Medical services, namely, gene therapy servicesACTIVE—
045Technology transfer services, namely, licensing of intellectual propertyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 31, 2016MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 30, 2016ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 28, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 26, 2015EX1GSOU EXTENSION 1 GRANTED—
Oct 26, 2015EXT1SOU EXTENSION 1 FILED—
Oct 26, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 28, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 3, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 3, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 11, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 23, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 23, 2015ALIEASSIGNED TO LIE—
Jan 2, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 2, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Jan 2, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 2, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 2, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 2, 2015DOCKASSIGNED TO EXAMINER—
Oct 10, 2014TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Oct 10, 2014PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Sep 27, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Sep 26, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 22, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance